KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Assets: 2011-2024

Historic Return on Assets for Emergent BioSolutions (EBS) over the last 14 years, with Dec 2024 value amounting to -0.12%.

  • Emergent BioSolutions' Return on Assets rose 19.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 19.00%. This contributed to the annual value of -0.12% for FY2024, which is 19.00% up from last year.
  • Emergent BioSolutions' Return on Assets amounted to -0.12% in FY2024, which was up 61.08% from -0.30% recorded in FY2023.
  • Emergent BioSolutions' 5-year Return on Assets high stood at 0.12% for FY2020, and its period low was -0.30% during FY2023.
  • Moreover, its 3-year median value for Return on Assets was -0.12% (2024), whereas its average is -0.16%.
  • Its Return on Assets has fluctuated over the past 5 years, first declined by 24bps in 2023, then increased by 19bps in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Return on Assets stood at 0.12% in 2020, then fell by 4bps to 0.08% in 2021, then dropped by 14bps to -0.07% in 2022, then dropped by 24bps to -0.30% in 2023, then climbed by 19bps to -0.12% in 2024.